Given the evidence that eIF4A1-mediated helicase activity may be a useful therapeutic target, we carried out a large-scale study to investigate the prevalence and clinical significance of the expression of eIF4A1 and its modulators in breast cancer, and found all these proteins to have striking relationships with survival. The gene discussed is EIF4A1; the disease is breast cancer.